Search Results - "Ma, Peiwen"

Refine Results
  1. 1

    Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors by Wang, Shuhang, Sun, Jingwei, Chen, Kun, Ma, Peiwen, Lei, Qi, Xing, Shujun, Cao, Zhongzheng, Sun, Shujun, Yu, Zicheng, Liu, Yarong, Li, Ning

    Published in BMC medicine (11-06-2021)
    “…Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying…”
    Get full text
    Journal Article
  2. 2

    Spatial Tuning of Light–Matter Interaction via Strain-Gradient-Induced Polarization in Freestanding Wrinkled 2D Materials by Cho, Chullhee, Zhang, Zhichao, Kim, Jin Myung, Ma, Peiwen J., Haque, Md Farhadul, Snapp, Peter, Nam, SungWoo

    Published in Nano letters (25-10-2023)
    “…To date, controlled deformation of two-dimensional (2D) materials has been extensively demonstrated with substrate-supported structures. However, interfacial…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer by Ma, Peiwen, Beatty, Pamela L, McKolanis, John, Brand, Randal, Schoen, Robert E, Finn, Olivera J

    Published in Frontiers in immunology (19-06-2019)
    “…Myeloid derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells that accumulate in circulation of cancer patients and at tumor…”
    Get full text
    Journal Article
  5. 5

    The current status and future of ADC therapy for small cell Lung Cancer: a promising approach by Zhou, Jiawei, Ma, Peiwen, Tang, Qiyu, Wang, Shuhang, Li, Ning

    Published in Journal of translational medicine (13-11-2023)
    “…Among the subset of 9 patients, a remarkable response rate of 77.8% was observed, with 7 patients showing partial responses (PRs). [...]ADCs offer a promising…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    The state of the art of bispecific antibodies for treating human malignancies by Wang, Shuhang, Chen, Kun, Lei, Qi, Ma, Peiwen, Yuan, Andy Qingan, Zhao, Yong, Jiang, Youwei, Fang, Hong, Xing, Shujun, Fang, Yuan, Jiang, Ning, Miao, Huilei, Zhang, Minghui, Sun, Shujun, Yu, Zicheng, Tao, Wei, Zhu, Qi, Nie, Yingjie, Li, Ning

    Published in EMBO molecular medicine (07-09-2021)
    “…Bispecific antibodies (bsAb) that target two independent epitopes or antigens have been extensively explored in translational and clinical studies since they…”
    Get full text
    Journal Article
  10. 10

    Clinical Investigations of CAR-T Cell Therapy for Solid Tumors by Chen, Kun, Wang, Shuhang, Qi, Dan, Ma, Peiwen, Fang, Yuan, Jiang, Ning, Wu, Erxi, Li, Ning

    Published in Frontiers in immunology (18-07-2022)
    “…Cell therapy is a distinguished targeted immunotherapy with great potential to treat solid tumors in the new era of cancer treatment. Cell therapy products…”
    Get full text
    Journal Article
  11. 11

    Near‐Field Nano‐Optical Imaging of van der Waals Materials by Kwon, Soyeong, Kim, Jin Myung, Ma, Peiwen J., Guan, Weilin, Nam, SungWoo

    Published in Advanced Physics Research (01-10-2023)
    “…Abstract 2D van der Waals (vdW) materials are emerging as the next generation platform for optical and electronic devices with their wide coverage of the…”
    Get full text
    Journal Article
  12. 12

    A Game-Theoretic Approach of Optimized Operation of AC/DC Hybrid Microgrid Clusters by Pan, Xuewei, Yang, Fan, Ma, Peiwen, Xing, Yijin, Zhang, Jinye, Cao, Lingling

    Published in Energies (Basel) (01-08-2022)
    “…To maximize the benefits of microgrid clusters, a general model and analysis method for studying the optimized operation of AC/DC microgrid clusters using…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Association between germ-line HLA and immune-related adverse events by Jiang, Ning, Yu, Yue, Zhang, Min, Tang, Yu, Wu, Dawei, Wang, Shuhang, Fang, Yuan, Zhang, Yu, Meng, Lin, Li, Yingying, Miao, Huilei, Ma, Peiwen, Huang, Huiyao, Li, Ning

    Published in Frontiers in immunology (13-09-2022)
    “…Background In recent years, significant progress has been made in immune checkpoint inhibitors (ICIs). However, accompanied by remarkable efficacy, a growing…”
    Get full text
    Journal Article
  15. 15

    Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials by Wang, Shuhang, Yang, Yuqi, Ma, Peiwen, Huang, Huiyao, Tang, Qiyu, Miao, Huilei, Fang, Yuan, Jiang, Ning, Li, Yandong, Zhu, Qi, Tao, Wei, Zha, Yan, Li, Ning

    Published in Molecular therapy. Oncolytics (17-03-2022)
    “…Tumor-associated macrophages (TAMs) exert integrated effects in all aspects of tumor progression, including tumor cell proliferation, angiogenesis, invasion,…”
    Get full text
    Journal Article
  16. 16

    Pan-cancer analysis of polo-like kinase family genes reveals polo-like kinase 1 as a novel oncogene in kidney renal papillary cell carcinoma by Zhao, Guo, Wang, Yuning, Zhou, Jiawei, Ma, Peiwen, Wang, Shuhang, Li, Ning

    Published in Heliyon (30-04-2024)
    “…Polo-like kinases (PLKs) are a kinase class of serine/threonine with five members that play crucial roles in cell cycle regulation. However, their biological…”
    Get full text
    Journal Article
  17. 17

    The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials by Wu, Dawei, Huang, Huiyao, Zhang, Minghui, Li, Ziwei, Wang, Shuhang, Yu, Yue, Fang, Yuan, Jiang, Ning, Miao, Huilei, Ma, Peiwen, Tang, Yu, Li, Ning

    Published in Journal of hematology and oncology (08-02-2022)
    “…The neoadjuvant and adjuvant anti-PD-1/PD-L1 treatment has been increasingly noticed. To summarize the global landscape of these clinical trials will provide…”
    Get full text
    Journal Article
  18. 18

    Targeting rare tumors: new focus for clinical research in China by Wang, Shuhang, Jiang, Yale, Miao, Huilei, Fang, Yuan, Jiang, Ning, Yu, Yue, Ma, Peiwen, Tang, Qiyu, Cui, Dandan, Fang, Hong, Huang, Huiyao, Fan, Qi, Sun, Chao, Yu, Anqi, Miao, Shuangman, Du, Jingting, Zhu, Jingxiao, Wang, Yuning, Li, Ning

    Published in EMBO molecular medicine (11-01-2023)
    “…Rare tumor has a huge unmet medical need without standard regimens, calling for novel therapeutic interventions. The National Cancer Center of China identified…”
    Get full text
    Journal Article
  19. 19

    Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood–brain barrier by Tang, Qiyu, Zhao, Guo, Fang, Hong, Jiang, Yale, Ma, Peiwen, Zhou, Jiawei, Liu, Dongyan, Xing, Shujun, Li, Gaoquan, Liu, Nian, Chen, Huiyu, Wang, Shuhang, Li, Ning

    Published in Acta pharmaceutica Sinica. B (01-06-2024)
    “…The current status of clinical trials utilizing nanoparticle drug delivery system (NDDS) for brain tumors was summarized. [Display omitted]…”
    Get full text
    Journal Article
  20. 20

    Rare tumors: a blue ocean of investigation by Wang, Shuhang, Ma, Peiwen, Jiang, Ning, Jiang, Yale, Yu, Yue, Fang, Yuan, Miao, Huilei, Huang, Huiyao, Tang, Qiyu, Cui, Dandan, Fang, Hong, Zhang, Huishan, Fan, Qi, Wang, Yuning, Liu, Gang, Yu, Zicheng, Lei, Qi, Li, Ning

    Published in Frontiers of medicine (01-04-2023)
    “…Advances in novel drugs, therapies, and genetic techniques have revolutionized the diagnosis and treatment of cancers, substantially improving cancer patients'…”
    Get full text
    Journal Article